Abstract
This study was conducted to compare the suppressive effects of calcium carbonate and calcium citrate on bone resorption in early postmenopause. Calcium citrate is thought to be better absorbed. We therefore tested the hypothesis that calcium as citrate is more effective than calcium as carbonate in suppressing parathyroid hormone (PTH) and C-terminal telopeptide. Twenty-five healthy postmenopausal women were recruited in this double blind crossover study. The subjects were randomly allocated to receive either 1,000 mg of elemental calcium as carbonate or 500 mg of calcium as citrate. They were given the alternate calcium dose 1 week later. Serum measurements of total and ionized calcium, phosphate, PTH, and CrossLaps were repeated 12 hours after each dose. Analysis of variance found no significant difference between measures for the two salts. Tests for equivalence indicated that 500 mg of calcium citrate may be superior to 1,000 mg of calcium carbonate in raising serum total and ionized calcium (P = 0.04 and 0.05, respectively). For all parameters measured, 500 mg of calcium citrate was at least as beneficial as 1,000 mg of calcium carbonate. Calcium citrate is at least as effective as calcium carbonate in suppressing PTH and C-terminal telopeptide cross-links, at half the dose. This may be because calcium as citrate is better absorbed than calcium as carbonate. If calcium citrate can be used in lower doses, it may be better tolerated than calcium carbonate.
Similar content being viewed by others
References
Nordin BEC, Wishart JM, Clifton PM et al (2004) A longitudinal study of bone-related biochemical changes at the menopause. Clin Endorinol 61:123–130
Need AG, Horowitz M, Morris HA et al (1991) Effects of three different proprietary calcium preparations on urine hydroxyproline excretion in postmenopausal women. Eur J Clin Nutr 45:357–361
Cleghorn DB, O’Loughlin PD, Schroeder BJ et al (2001) An open, crossover trial of calcium-fortified milk in prevention of early postmenopausal bone loss. Med J Aust 175:242–245
Prince RL, Devine A, Dhaliwal SS et al (2006) Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern Med 166:869–875
Reginster JY, Denis D, Bartsch V et al (1993) Acute biochemical variations induced by four different calcium salts in healthy male volunteers. Osteoporos Int 3:271–275
Heller HJ, Greer LG, Haynes SD et al (2000) Pharmacokinetic and pharmacodynamic comparison of two calcium supplements in postmenopausal women. J Clin Pharmacol 40:1237–1244
Nordin BEC, Need AG, Morris HA et al (1999) Biochemical variables in pre- and postmenopausal women: reconciling the calcium and estrogen hypotheses. Osteoporos Int 9:351–357
Australian Government Department of Health and Aging and National Health and Medical Research Council (2006) Nutrient reference values for Australia and New Zealand. Canberra, Australian Government
Zikan V, Haas T, Stepan JJ (2001) Acute effects in healthy women of oral calcium on the calcium–parathyroid axis and bone resorption as assessed by serum β-crosslaps. Calcif Tissue Int 68:352–357
Brent GA, LeBoff MS, Seely EW et al (1988) Relationship between the concentration and rate of change of calcium and serum intact parathyroid hormone levels in normal humans. J Clin Endocrinol Metab 76:944–950
Blumsohn A, Herrington K, Hannon RA et al (1994) The effect of calcium supplementation on the circadian rhythm of bone resorption. J Clin Endocrinol Metab 79:730–735
Kenny AM, Prestwood KM, Biskup B et al (2004) Comparison of the effects of calcium loading with calcium citrate or calcium carbonate on bone turnover in postmenopausal women. Osteoporos Int 15:290–294
Heaney RP, Dowell S, Bierman J et al (2001) Absorbability and cost effectiveness in calcium supplementation. J Am Coll Nutr 20:239–246
Nordin BEC (1997) Calcium and osteoporosis. Nutrition 7/8:664–685
Reid IR, Mason B, Horne A et al (2006) Randomized controlled trial of calcium in healthy older women. Am J Med 119:777–785
O’Connell D, Madden A, Murray A, Heaney R, Kerzner L (2005) Effects of proton pump inhibitors on calcium carbonate absorption in women: a randomised crossover trial. Am J Med 118:778–781
Dawson-Huges B, Dallal GE, Krall EA et al (1990) A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N Engl J Med 323:878–883
Acknowledgements
This trial is registered as a clinical trial in the Australian Clinical Trial Registry (ACTRN 012606000458538). This study was funded by a research grant from the Royal Adelaide Hospital and Institute of Medical and Veterinary Science Research Committee.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Thomas, S.D.C., Need, A.G., Tucker, G. et al. Suppression of Parathyroid Hormone and Bone Resorption by Calcium Carbonate and Calcium Citrate in Postmenopausal Women. Calcif Tissue Int 83, 81–84 (2008). https://doi.org/10.1007/s00223-008-9148-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00223-008-9148-z